Hyperalgesia Produced by Intrathecal Substance P and Related Peptides: Desensitization and Cross Desensitization

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1984 Jun 1

PMID 6203593

Citations 11

Authors

S M Moochhala

J Sawynok

Affiliations

Soon will be listed here.

Abstract

The hyperalgesic effect of intrathecally administered substance P (SP), physalaemin, eledoisin and eledoisin-related peptide (ERP) was investigated in the rat tail flick test. Hyperalgesia produced by SP (2.5-15 micrograms, 1.9-11 nmol) was maximal 10-20 min after injection, lasted 30 min and was dose-related. The effect was mimicked by all of the peptides examined. The rank order of potency was physalaemin greater than SP greater than eledoisin greater than ERP. Desensitization to the hyperalgesic effect of SP was produced by three repeated intrathecal injections. Rats desensitized to SP no longer responded to physalaemin or ERP, indicating cross-desensitization. Phentolamine continued to produce hyperalgesia following such desensitization. The demonstration of a hyperalgesic effect for SP provides further support for a role for SP in nociceptive transmission. The receptor mediating this effect appears to be a SP-P subtype. Cross-desensitization between peptides suggests an action on the same receptor.

Citing Articles

Opioids Resistance in Chronic Pain Management.

Morrone L, Scuteri D, Rombola L, Mizoguchi H, Bagetta G Curr Neuropharmacol. 2017; 15(3):444-456.

PMID: 28503117 PMC: 5405610. DOI: 10.2174/1570159X14666161101092822.

Antinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeys.

Ko M, Naughton N J Pain. 2009; 10(5):509-16.

PMID: 19231294 PMC: 2797530. DOI: 10.1016/j.jpain.2008.11.006.

Design, synthesis, and biological evaluation of novel bifunctional C-terminal-modified peptides for delta/mu opioid receptor agonists and neurokinin-1 receptor antagonists.

Yamamoto T, Nair P, Davis P, Ma S, Navratilova E, Moye S J Med Chem. 2007; 50(12):2779-86.

PMID: 17516639 PMC: 2365895. DOI: 10.1021/jm061369n.

Contribution of substance P and neurokinin A to the differential injury-induced thermal and mechanical responsiveness of lamina I and V neurons.

Mazario J, Basbaum A J Neurosci. 2007; 27(4):762-70.

PMID: 17251415 PMC: 6672913. DOI: 10.1523/JNEUROSCI.2992-06.2007.

Role of NK-1 neurotransmission in opioid-induced hyperalgesia.

King T, Gardell L, Wang R, Vardanyan A, Ossipov M, Malan Jr P Pain. 2005; 116(3):276-288.

PMID: 15964684 PMC: 1440305. DOI: 10.1016/j.pain.2005.04.014.

References

Lembeck F, Fischer G . [Crossed tachyphylaxis of peptides]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1967; 258(5):452-6. View

Konishi S, Otsuka M . The effects of substance P and other peptides on spinal neurons of the frog. Brain Res. 1974; 65(3):397-410. DOI: 10.1016/0006-8993(74)90231-5. View

Konishi S, Otsuka M . Excitatory action of hypothalamic substance P on spinal motoneurones of newborn rats. Nature. 1974; 252(5485):734-5. DOI: 10.1038/252734a0. View

Hokfelt T, Kellerth J, Nilsson G, PERNOW B . Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neurons. Brain Res. 1975; 100(2):235-52. DOI: 10.1016/0006-8993(75)90481-3. View

Frederickson R, Burgis V, Harrell C, Edwards J . Dual actions of substance P on nociception: possible role of endogenous opioids. Science. 1978; 199(4335):1359-62. DOI: 10.1126/science.204012. View

Hokfelt T, Ljungdahl A, Steinbusch H, Verhofstad A, Nilsson G, Brodin E . Immunohistochemical evidence of substance P-like immunoreactivity in some 5-hydroxytryptamine-containing neurons in the rat central nervous system. Neuroscience. 1978; 3(6):517-38. DOI: 10.1016/0306-4522(78)90017-9. View

Basbaum A, Fields H . Endogenous pain control mechanisms: review and hypothesis. Ann Neurol. 1978; 4(5):451-62. DOI: 10.1002/ana.410040511. View

Yaksh T, Farb D, Leeman S, Jessell T . Intrathecal capsaicin depletes substance P in the rat spinal cord and produces prolonged thermal analgesia. Science. 1979; 206(4417):481-3. DOI: 10.1126/science.228392. View

Hayes A, Tyers M . Effects of intrathecal and intracerebroventricular injections of substance P on nociception in the rat and mouse [proceedings]. Br J Pharmacol. 1979; 66(3):488P. PMC: 2043650. View

10.

Oehme P, Hilse H, Morgenstern E, GORES E . Substance P: does it produce analgesia or hyperalgesia?. Science. 1980; 208(4441):305-7. DOI: 10.1126/science.6154313. View

11.

Reddy S, Yaksh T . Spinal noradrenergic terminal system mediates antinociception. Brain Res. 1980; 189(2):391-401. DOI: 10.1016/0006-8993(80)90099-2. View

12.

Otsuka M, Yanagisawa M . The effects of substance P and baclofen on motoneurones of isolated spinal cord of the newborn rat. J Exp Biol. 1980; 89:201-14. DOI: 10.1242/jeb.89.1.201. View

13.

Sandberg B, Lee C, Hanley M, Iversen L . Synthesis and biological properties of enzyme-resistant analogues of substance P. Eur J Biochem. 1981; 114(2):329-37. DOI: 10.1111/j.1432-1033.1981.tb05152.x. View

14.

Piercey M, Dobry P, SCHROEDER L, Einspahr F . Behavioral evidence that substance P may be a spinal cord sensory neurotransmitter. Brain Res. 1981; 210(1-2):407-12. DOI: 10.1016/0006-8993(81)90918-5. View

15.

SHARE N, Rackham A . Intracerebral substance P in mice: behavioral effects and narcotic agents. Brain Res. 1981; 211(2):379-86. DOI: 10.1016/0006-8993(81)90709-5. View

16.

Hylden J, Wilcox G . Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res. 1981; 217(1):212-5. DOI: 10.1016/0006-8993(81)90203-1. View

17.

Proudfit H, Hammond D . Alterations in nociceptive threshold and morphine-induced analgesia produced by intrathecally administered amine antagonists. Brain Res. 1981; 218(1-2):393-9. DOI: 10.1016/0006-8993(81)91318-4. View

18.

Rackham A, Therriault M, Wood P . Substance P: evidence for spinal mediation of some behavioural effects. Neuropharmacology. 1981; 20(8):753-5. DOI: 10.1016/0028-3908(81)90224-0. View

19.

Doi T, Jurna I . Intrathecal substance P depresses the tail-flick response - antagonism by naloxone. Naunyn Schmiedebergs Arch Pharmacol. 1981; 317(2):135-9. DOI: 10.1007/BF00500069. View

20.

Hunt S, Kelly J, Emson P, Kimmel J, Miller R, Wu J . An immunohistochemical study of neuronal populations containing neuropeptides or gamma-aminobutyrate within the superficial layers of the rat dorsal horn. Neuroscience. 1981; 6(10):1883-98. DOI: 10.1016/0306-4522(81)90029-4. View